Track the 클래시스 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 클래시스 has published 14 reports. The latest transaction was disclosed on 16 July 2026 (Purchase). Among the most active insiders: BCPECenturInvestments,LP. Every trade is accessible without an account.
12
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
6 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
클래시스 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el bienestar y la salud.